Page last updated: 2024-09-03

1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine and Dermatitis, Atopic

1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine has been researched along with Dermatitis, Atopic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Hassani, M; Billings, SD; Howard, KM; Ishii, S; Mousdicas, N; Perkins, SM; Shimizu, T; Travers, JB; Yi, Q; Zhang, Q1

Other Studies

1 other study(ies) available for 1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine and Dermatitis, Atopic

ArticleYear
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
    The Journal of clinical investigation, 2005, Volume: 115, Issue:10

    Topics: Animals; Calcium; Cell Line; Dermatitis, Atopic; Dinitrofluorobenzene; Drug Hypersensitivity; Drug Synergism; Humans; Hypersensitivity, Delayed; Inflammation; Interleukin-10; Lipopolysaccharides; Mice; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Skin; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Th1 Cells; Th2 Cells

2005